Journal of Vaccines & Vaccination

Jean Lang

Biography

Jean Lang joined Sanofi Pasteur R&D in 1991 and Pharma in1989, was on the Lyon faculty of Medicine (Clinical Pharmacology Assistant 1983-1988) and Lyon 1 University of Biological Sciences (Experimental Pharmacology Assistant 1982-1988), M.D. (1983), Clinical Pharmacokinetics MSc (1984) and PhD (1987) with his thesis on Experimental Pharmacology. At J&J from 1989 -1991,he worked on rHuEPO, Mabs and various Biotech RD projects.

Research Interest

In addition with medical epidemiology and clinical trials, for dengue he was first working with a live attenuated vaccine from the Mahidol University in Thailand since 1995, and then since 2001, the second generation Dengue tetravalent vaccine using recombinant technology, which completed Phase IIb trials in Q3 2012 and Phase III vaccination in Q1 2013 (positive results published in 2014). He is an active member of the ASTMH since 1999